Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation
Clin Res
.
1993 Oct;41(3):482-6.
Author
D E Singer
1
Affiliation
1
General Internal Medicine Unit, Massachusetts General Hospital, Boston 02114.
PMID:
8403778
No abstract available
MeSH terms
Atrial Fibrillation / drug therapy*
Cerebrovascular Disorders / prevention & control*
Humans
Randomized Controlled Trials as Topic / standards*
Therapeutic Human Experimentation*
Warfarin / therapeutic use*
Substances
Warfarin